14May 2024
Study Reveals Causal Link Between SGLT2 Inhibition and Venous Thrombolism in Cardiac Mortality

Study Reveals Causal Link Between SGLT2 Inhibition and Venous Thrombolism in Cardiac Mortality

A Mendelian randomization (MR) study ascertained venous thrombolism's role in mediating sodium-glucose cotransporter 2 (SGLT2) inhibition's impact on death due to cardiac causes. Genetic proxies for SGLT2 inhibition were identified, and MR analysis was conducted to explore the causal associations. The results revealed that SGLT2 inhibition correlated with a decreased risk of death from cardiac causes, while venous thrombolism increased this risk. Mediation analysis indicated that SGLT2 inhibition potentially influences cardiac mortality through venous thrombolism. Moreover, SGLT2 inhibition was associated with lower risks of cardiac arrest and coronary heart disease. These findings underscore the causal relationship between SGLT2 inhibition and venous thrombolism, shedding light on potential mechanisms underlying cardiac mortality.

  • #cardiology

Like

Save

Share